Published in Int J Impot Res on May 01, 2014
The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology (1997) 13.27
Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med (1998) 12.67
Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol (2010) 3.55
Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology (1999) 2.57
Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man. Xenobiotica (1999) 2.03
The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin (2004) 2.03
Development and validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction. Int J Impot Res (2004) 1.83
Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol (2002) 1.65
When an erection alone is not enough: biopsychosocial obstacles to lovemaking. Int J Impot Res (2002) 1.53
Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis. Ann Intern Med (2009) 1.53
EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology (1999) 1.52
Tadalafil pharmacokinetics in healthy subjects. Br J Clin Pharmacol (2006) 1.40
Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology (2003) 1.39
Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl (2002) 1.13
Long-term safety and efficacy of tadalafil 5 mg dosed once daily in men with erectile dysfunction. J Sex Med (2008) 1.07
Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial. J Androl (2005) 1.04
The psychological and interpersonal relationship scales: assessing psychological and relationship outcomes associated with erectile dysfunction and its treatment. Arch Sex Behav (2004) 0.98
Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US. Int J Impot Res (2006) 0.93
Safety, efficacy, and pharmacokinetic overview of low-dose daily administration of tadalafil. J Sex Med (2009) 0.89
Duration of action of sildenafil citrate in men with erectile dysfunction. J Sex Med (2004) 0.89
Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction. J Sex Med (2013) 0.87
Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study. Int J Clin Pract (2007) 0.84
Psychosocial impact and effectiveness of tadalafil among treatment-naïve and previously-treated men with erectile dysfunction in Saudi Arabia and other Gulf-region countries. Curr Med Res Opin (2008) 0.81
A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors. J Sex Med (2011) 0.80